Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

102.11
Delayed Data
As of Jun 24
 -3.17 / -3.01%
Today’s Change
101.03
Today|||52-Week Range
185.92
-34.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues347.2M386.2M404.9M369.0M
 
 
 
 
 
Cost of Goods Sold7.7M2.8M17.3M700.0K
 
 
 
 
 
Depreciation And Amortization8.4M8.2M8.0M--
 
 
 
 
 
Operating ExpensesGross Income331.1M375.2M379.6M368.3M
 
 
 
 
 
General Expenses159.4M-11.9M224.5M4.6M
 
 
 
 
 
Research And Development49.4M5.4M75.9M-400.0K
 
 
 
 
 
Total Operating Expenses175.5M-858.0K249.8M5.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income171.7M387.1M155.1M363.7M
 
 
 
 
 
Interest Expense On Debt1.3M834.0K546.0K600.0K
 
 
 
 
 
Other Expenses-2.1M350.6M1.5M800.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income168.3M736.9M156.0M363.9M
 
 
 
 
 
Income Taxes-69.1M-272.4M-51.4M-128.4M
 
 
 
 
 
Net Income99.2M464.4M104.6M235.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.1M45.5M45.7M45.4M
 
 
 
 
 
Shares To Calculate EPS Diluted51.9M50.2M49.7M48.7M
 
 
 
 
 
 
Earnings Per ShareEPS$1.91$9.24$2.10$4.84
 
 
 
 
 
EPS Diluted$1.91$9.24$2.10$4.84